Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Biotech Stocks and Advisory Committees: No News Is Good News?

01 Feb 2012

• By Michael McCaughan

Related Content

"Priority" Review Slow Down: The Prasugrel Delay

01 Oct 2008

Adasuve’s Extensive REMS Proposal Raises Questions About Whether It Could Work In Practice

19 Dec 2011

Skipping the Advisory Committee, but Getting the Advice

01 Nov 2011

Related Companies

Pfizer Inc.

Affymax, Inc.

Takeda Pharmaceutical Co. Ltd.

Alexza Pharmaceuticals, Inc.

Allergan plc

Juniper Pharmaceuticals

Amgen, Inc.

Eisai Co., Ltd.

NeurogesX, Inc.

Ironwood Pharmaceuticals, Inc.

Amarin Corp plc

Eli Lilly and Company

Chelsea Therapeutics International, Ltd.

Additional Topics

Advisory Committees BioPharmaceutical

More from US FDA Performance Tracker

More from Regulatory Trackers

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.